Oncotelic Therapeutics (OTLC) Non-Current Debt (2022 - 2024)
Oncotelic Therapeutics (OTLC) reported Non-Current Debt of $20,000 for FY2020.
Powered by 
Analysis
Oncotelic Therapeutics (OTLC) Non-Current Debt (2022 - 2024) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,109.83 Bn | 1,078.42 Bn | 19.71 Bn | 47.86 Bn |
| 2 | Johnson & Johnson | 610.61 Bn | 529.14 Bn | 17.26 Bn | 37.34 Bn |
| 3 | AbbVie | 500.66 Bn | 473.77 Bn | 12.70 Bn | 62.48 Bn |
| 4 | Merck | 354.64 Bn | 309.02 Bn | 12.21 Bn | 51.08 Bn |
| 5 | Novartis Ag | 291.14 Bn | 255.13 Bn | 11.24 Bn | 1.96 Bn |
| 6 | Astrazeneca | 254.18 Bn | 227.87 Bn | 12.86 Bn | 23.68 Bn |
| 7 | Amgen | 229.46 Bn | 184.86 Bn | 7.24 Bn | 51.86 Bn |
| 8 | Gilead Sciences | 190.33 Bn | 164.53 Bn | 6.22 Bn | 23.83 Bn |
| 9 | Pfizer | 167.92 Bn | 114.57 Bn | 10.94 Bn | 60.50 Bn |
| 10 | Oncotelic Therapeutics | 8.28 Mn | 7.42 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 380,000.00 |
| Dec 31, 2023 | 364,000.00 |
| Dec 31, 2022 | 347,819.00 |
API Access
Oncotelic Therapeutics Non-Current Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-debt&ticker=OTLC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-debt", "ticker": "OTLC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-debt&ticker=OTLC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();